These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis in 2 patients with end-stage renal disease on hemodialysis. Kim RH, Ma L, Hayat SQ, Ahmed MM. J Clin Rheumatol; 2006 Jun 21; 12(3):134-6. PubMed ID: 16755242 [Abstract] [Full Text] [Related]
23. [Nephrogenic fibrosing dermopathy]. Shelekhova KV, Kazakov DV, Michal M. Arkh Patol; 2006 Jun 21; 68(1):42-3. PubMed ID: 16544538 [Abstract] [Full Text] [Related]
24. Nephrogenic fibrosing dermopathy with recurrence after allograft failure. Goddard DS, Magee CC, Lazar AJ, Miller DM. J Am Acad Dermatol; 2007 May 21; 56(5 Suppl):S109-11. PubMed ID: 17434031 [No Abstract] [Full Text] [Related]
25. Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Grobner T. Nephrol Dial Transplant; 2006 Apr 21; 21(4):1104-8. PubMed ID: 16431890 [No Abstract] [Full Text] [Related]
26. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review. Daram SR, Cortese CM, Bastani B. Am J Kidney Dis; 2005 Oct 21; 46(4):754-9. PubMed ID: 16183432 [Abstract] [Full Text] [Related]
36. ACE inhibitors for all--'Hope' for the heart and failure for the kidneys? Goldsmith D. J Hum Hypertens; 2001 Mar 13; 15(3):147-51. PubMed ID: 11317197 [No Abstract] [Full Text] [Related]